WHO ICTRP trial
The ability of essential amino acids to boost muscle mass in people who suffer…
CTRI/2024/02/063107 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2024/02/063107 |
|---|---|
| Public title | The ability of essential amino acids to boost muscle mass in people who suffer from muscle loss. |
| Scientific title | To evaluate the effectiveness of essential amino acids in primary sarcopenia - RACE |
| Primary sponsor | pimary investigator |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: M625- Muscle wasting and atrophy, not elsewhere classified |
| Interventions | Intervention1: Essential Amino Acid(EAA): Essential Amino Acid(EAA)( L Lysine 378mg, L Leucine 342 mg, L Arginine 315 mg, Valine 302mg, L Methionine 302mg, Iso Leucine 302 mg, L Phenylalanine 203 mg, L Threonine 203 mg, L Histidine 158mg, L… |
| Registration date | Feb 23, 2024 |
| Target size | 50 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: